Introduction
Herba Siegesbeckiae (HS, Xixiancao in Chinese), as a medicinal herb, was first documented in the Newly Revised Materia Medica (Xinxiu Bencao), issued in A.D. 659 in the Tang Dynasty of China. It functions to eliminate wind-dampness and relieve joint pain (1, 2) . In the 2015 edition of Chinese Pharmacopeia, it is recorded that the aerial parts of three Siegesbeckia genus plants Siegesbeckia pubescens Makino, S. orientalis L. and S. glabrescens Makino are used as HS (3) . In the clinic, HS is widely prescribed to treat inflammatory diseases such as furuncle, arthritis and gout (4) . Some preparations made solely from this herb are commercially available (e.g. Xixian Pill/ Tablet) in China and European countries. Of these preparations, the patent drug Joint and Muscle Relief Tablets™ produced by Phynova is the first traditional Chinese medicine licensed under the Traditional Herbal Medicinal Products Directive in the United Kingdom (5). Although there is no contention regarding the use, and efficacy, of HS in the treatment of inflammatory disorders, the mode and mechanism of action of this herb are poorly understood.
Pharmacological studies have demonstrated that HS possesses anti-inflammatory effects in animal models, such as xylene-induced ear edema in mice; cottonball-induced granuloma (6) , collagenase-induced paw edema (7) and urate-induced synovitis in rats (4); as well as rheumatoid arthritis induced by mixed arthrogen monoclonal antibody in mice (8) . In vitro studies have shown that HS inhibits inflammatory mediators by suppressing the MAPK-and NF-κB-pathways in LPSstimulated RAW264.7 cells (9) . Kirenol, a natural compound occuring in HS, has been reported to inhibit NF-κB activity and exert anti-inflammatory effects in collagen-induced arthritic rats (10) . However, these mechanistic studies do not address whether HS/kirenol affect(s) molecular events upstream and/or downstream of NF-κB and MAPKs, which are downstream effectors of troll-like receptor 4 (TLR4). TLR4 is part of a receptor complex that recognizes and responds to the bacteria lipopolysaccharide (LPS) ligand (11, 12) . TLR4 signalling pathway activation has been implicated in inflammatory disorders. TLR4 signalling activates transcription factors such as NF-κB, AP-1 and IRF3. These proteins are key inflammatory response mediators (13) . In this study we found that inhibition of the IRAK4/MAPKs/AP-1, IRAK4/MAPKs/NF-κB, IRAK4/PI3K/NF-κB and TRAF3/TBK1/IRF3 pathways is associated with the inhibitory effects of HS on inflammatory mediators in LPS-stimulated RAW264.7 cells. These novel findings provide additional justification for the clinical application of HS in the treatment of inflammatory disorders.
Materials and Methods

Reagents and materials
LPS from Escherichia coli O55:B5, dimethyl sulfoxide (DMSO), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and Griess reagent were obtained from Sigma Chemicals Ltd. (St. Louis, MO, USA). Penicillin, streptomycin, Dulbecco's Modified Eagle Medium (DMEM) and foetal bovine serum (FBS) were purchased from Hyclone (Logan, UT, USA). Cyclooxygenase-2 (COX-2), Inducible nitric oxide synthase (iNOS), TNF receptor associated factor protein 3 (TRAF3), IKKα/β, PI3K, phospho-PI3K p85 (Tyr458)/p55 (Tyr199), phospho-IKKα/β (Ser176/180), IκBα, phospho-IκBα (Ser32), NF-κB p50, IFN regulatory factor 3 (IRF3), phospho-IRF3 (Ser396), extracellular signal-regulated kinase (ERK), phospho-ERK (Thr202/Tyr204), c-Jun N-terminal kinase (JNK), phospho-JNK (Thr183/Tyr185), p38 mitogen-activated protein kinase (p38), phospho-p38 (Thr180/Tyr182), TGFβ-activated kinase 1 (TAK1), phospho-TAK1 (Ser412), interleukin-1 receptor-associated kinase 1 (IRAK1), IRAK4, TANK-binding kinase 1 (TBK1), phospho-TBK1 (Ser172) and GAPDH monoclonal antibodies were obtained from Cell Signalling Technology (Boston, MA, USA). TNF receptor associated factor protein 6 (TRAF6), Akt, phospho-Akt (Ser473), NF-κB p65, phospho-NF-κB p65 (Ser536), c-Jun, phosphor-c-Jun (Ser63), Pol II (H-224) antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Acetonitrile (ACN, HPLC grade) was obtained from RCI Labscan Limited (Thailand). A Milli-Q system (Millipore, MA, USA) was used to prepare ultra-pure water for HPLC analyses. Ethanol (absolute) was from Merck (Darmstadt, Germany). Other materials used in bioassays were from Life Technologies Inc. (GIBICO, USA).
Herbal materials
Three Siegesbeckia genus plants are used as origins of HS in China. However, HS derived from S. orientalis is the most commonly used. In this study, we used the dried aerial part of S. orientalis, which originates in Hubei province, China (Longitudes: 108-116°E, latitudes: 29-33°N). The herb was purchased from the Hubei Shen Nong Traditional Chinese Medicine Co. Ltd and authenticated by Professor Hubiao Chen (Hong Kong Baptist University, HKBU). A voucher specimen (No.20141101) has been deposited at the School of Chinese Medicine, HKBU.
HS is traditionally used in the forms of decoction (extraction using water) and pill made from herb powder, suggesting that the bioactive components of HS may be polar and/or non-polar. Previously, we extracted the herb with three different solvents including water, 50% ethanol and 95% ethanol; and compared the inhibitory effect of the three extracts on NO production in LPS-stimulated RAW 264.7 cells. Results indicated that the extract prepared with 50% ethanol possesses the most potent inhibitory effect on NO production (14) . Thus, we used 50% ethanol to extract the herb in this work. HS (10 g) was grounded and macerated for 1 h with 100 mL of 50% ethanol at room temperature (25 ± 2°C ), and then extracted by refluxing twice for 1 h each. The extracts were filtered and combined after cooling; the filtrate and washings were combined and then concentrated by rotary evaporation under reduced pressure to remove the solvent. The concentrated extracts were rapidly frozen at −80°C, and then dried in a freeze-dryer (Virtis freeze mobile, Virtis Co., Gardiner, USA). The yield of the extract (HS for short) was 18.03%. To prepare the sample solution for bioassays, HS was freshly dissolved in DMSO, filtered 2.7. Real-time polymerase chain reaction analysis RAW264.7 cells were seeded in 6-well plates (1.0 × 10 5 cells/mL) and allowed for adhere over night. After pretreatment with HS (80 μg/mL) for 1 h, the cells were incubated in the presence or absence of LPS (100 ng/ mL) for another 16 h. Trizol reagent (Invitrogen, USA) was used to prepare total RNA. Five μg of RNA was used for reverse transcription by oligo-dT using the SuperScript II Reverse Transcription Kit (Invitrogen, USA). The following primers were used: iNOS (Sense 5'-AGCAACTACTGCTGGTGGTG-3' and anti-sense 5'-TCTTCAGAGTCTGCCCATTG-3'), COX-2 (Sense 5'-CTGGAACATGGACTCACTCAGTTTG-3' and anti-sense 5'-AGGCCTTTGCCACTGCTTGT-3'), IL-1β (Sense 5'-GAAGAAGAGCCCATCCTCTG-3' and anti-sense 5'-TCATCTCGGAGCCTGTAGTG-3'), IL-6 (Sense 5'-AGTCCGGAGAGGAGACTTCA-3' and antisense 5'-ATTTCCACGATTTCCCAGAG-3'), TNF-α (Sense 5'-ATGAGAAGTTCCCAAATGGC-3' and antisense 5'-CTCCACTTGGTGGTTTGCTA-3' ), mPGES-1 (Sense 5'-ATGAGGCTGCGGAAGAAGG-3' and antisense 5'-GCCGAGGAAGAGGAAAGGATAG-3'), MCP-1 (Sense 5'-AATGCTAACGCCACCGAGAG-3' and antisense 5'-CCTTGTTCTGCTCCTCATAGTCC-3'), MIP-1α (Sense 5'-CCCAGCCAGGTGTCATTTTCC-3' and anti-sense 5'-GCATTCAGTTCCAGGTCAGTG-3'), RANTES (Sense 5'-CATATGGCTCGGACACCA-3' and anti-sense 5'-ACACACTTGGCGGTTCCT-3'), GAPDH (Sense 5'-GGCCTTCCGTGTTCCTACC-3' and antisense 5'-TGCCTGCTTCACCACCTTC-3'); Real-time PCR analysis was conducted using SYBR green reaction mixture in the ABI 7500 Fast Real-time PCR System (Applied Biosystems, USA) (20).
Western blotting
RAW 264.7 cells were seeded in 60-mm-diameter culture dishes (2 × 10 5 cells/mL) and allowed to adhere overnight. The cells were treated with HS at indicated concentrations for 1 h, and then in the presence or absence of LPS (100 ng/mL) for indicated periods (30, 60 min; or 24 h). Cell total extract, cytosolic fraction and nuclear fraction were prepared, respectively. Soluble lysates were immunoblotted with the designated antibodies, and signals were detected by ECL detection reagents (Amersham Biosciences, USA) (21).
Statistical analysis
Data were presented as the mean ± SD of at least three triplicate determinations. Statistical differences were determined using one-way ANOVA followed by Tukey's multiple comparisons test. GraphPad Prism 5.0 (GraphPad Software, San Diego, CA) was used for statistical analyses. P < 0.05 was considered to be statistically significant. with a syringe filter (0.22 µm), and then diluted with cell culture medium to various concentrations.
For the quality control of the prepared HS, HPLC analyses were performed on an Agilent 1260 series HPLC-DAD system using a previously described method (15) with some modifications. The separation was conducted on an Alltima TM C-18 analytical column (250 mm × 4.6 mm I.D., 5 µm) with a gradient mobile phase of solvent A (ultra-pure water) and solvent B (acetonitrile). The HPLC elution profile was as follows: 0-6 min, 30% B; 6-20 min, 30-45% B; 20-30 min, 45% B. The flow rate was maintained at 1.0 mL/min and the column temperature was set at 25°C. The chromatograms were monitored with the DAD detector at a wavelength of 215 nm. Each sample of 20 μL was injected for analysis.
Cell culture
The RAW267.4 murine macrophage cell line (ATCC TIB-71) was obtained from the American Type Culture Collection (Manassas, VA, USA). The cells were cultured in DMEM at 37°C with 5% CO 2 in a humidified incubator. Heat inactivated FBS (5%) and penicillin/ streptomycin antibiotic cocktail (1%) were included in the culture (16).
Cell viability assay
RAW264.7 cells were seeded in 96-well plates (5 × 10 3 cells/well) and allowed to adhere overnight. The cells were treated with HS at indicated concentrations for 1h, and further treated in the presence or absence of LPS (100 ng/mL) for another 24 h. The final concentration of DMSO in the cell culture medium was less than 0.05% (v/v). Cell viability was evaluated using the MTT assay as described (17).
Enzyme-linked immunosorbent assay (ELISA)
RAW264.7 cells were seeded in 24-well plates (1.5 × 10 5 cells/well) and allowed to adhere overnight. The cells were treated with indicated concentrations (µg/mL) of HS for 1 h, and then in the presence or absence of LPS (100 ng/mL) for another 24 h. ELISA kits purchased from eBioscience (San Diego, CA, USA) were used to determine PGE 2 , MCP-1, MIP-1α, IL-1, IL-6, TNF-α and RANTES in the supernatants of the cell cultures following manufacturer's instructions (18).
Nitric oxide (NO) production measurement
The supernatant of cultured RAW 264.7 cells obtained in Section 2.5 was used to measure NO production by determining the accumulated nitrite formed using the Griess reagent according to manufacturer's instructions (Sigma) (19).
Results and Discussion
In clinic, HS is commonly prescribed for treating hypertension, malaria, neurasthenia, hepatitis, and inflammatory diseases such as rheumatic arthritis and gout. Phytochemical investigations revealed that this herb contains various types of compounds such as diterpenoids, sesquiterpenoids and flavonoids. Diterpenoids are reported as being major bioactive components of HS (22) . Kirenol and darutigenol are two diterpenoids abundant in HS. Kirenol has been shown to inhibit NF-κB activity and exert anti-inflammatory effects in collagen-induced arthritic rats (10) . In this study, the HPLC chromatogram showed that kirenol and darutigenol were present in HS (Figure 1) . The mean contents of kirenol and darutigenol in HS were 0.51% and 0.22%, respectively. Further studies are required to identify the anti-inflammatory compounds in HS.
Previous studies indicated that the MAPKs and NF-κB signalling pathways play essential roles in the inhibitory effects of HS on inflammatory mediators (9, 20) . MAPKs and NF-κB are components of TLR4 signalling cascades. We believe that inhibition of TLR4 signalling pathways contributes to the inhibitory effects of HS on inflammatory mediators.
In this work, LPS-stimulated RAW264.7 macrophage cells were used as the TLR4-activated cell model to investigate the inhibitory effect of HS on inflammatory mediators. To determine sub-lethal concentrations of HS, MTT assays were first conducted. In the presence or absence of 100 ng/mL of LPS, the viability of RAW264.7 cells was not significantly altered during a 24-h treatment with up to 120 μg/mL of HS (Figure 2A ). HS concentrations of 20, 40 and 80 μg/mL were used in subsequent assays.
TLR4 transduces signals through the MyD88-dependent and MyD88-independent pathways, which are mainly mediated by the activation of transcription factors NF-κB, AP-1 and IRF3. Upon LPS stimulation, NF-κB and AP-1 are activated via the MyD88-dependent pathway, and IRF3 is activated via the MyD88-independent pathway in macrophages (13) . We have determined the effect of HS on pro-inflammatory mediators regulated by the three transcription factors in LPS-induced RAW264.7 cells, and observed that HS concentration-dependently reduced the production of PGE 2 (regulated by NF-κB), MCP-1, MIP-1α (regulated by AP-1), and RANTES (regulated by IRF3) ( Figure  2B) , and lowered mRNA levels of iNOS, COX-2, IL-1β, IL-6, TNF-α, mPGES-1, MCP-1, MIP-1α and RANTES ( Figure 2C) . Additionally, HS inhibited other NF-κB-regulated inflammatory mediators that have previously been reported (9, 20) . These mediators have been examined (Supplementary Figure 1S , http://www. biosciencetrends.com/action/getSupplementalData. php?ID=26) and discussed in the subsequent sections.
We determined the effect of HS on the nuclear localization of transcription factors NF-κB, AP-1 and IRF3 in LPS-induced RAW264.7 cells. Our results indicate that the nuclear protein levels of NF-κB subunits (p65 and p50), AP-1 subunits (c-Jun and c-Fos) and IRF3 were markedly increased upon LPS stimulation. HS concentration-dependently reversed the increment ( Figure 3A) . Moreover, LPS-induced downregulation of p65, p50, c-Jun and c-Fos in the cytoplasm was dose-dependently inhibited by HS ( Figure 3B ). Cytoplasmic IRF3 levels were not significantly altered by the treatments (data not shown). These results demonstrate that HS inhibits the production of proinflammatory mediators regulated by NF-κB, AP-1 and IRF3, suggesting that both MyD88-dependent and MyD88-independent pathways are involved in the antiinflammatory effects of HS. Upon activation of MyD88-dependent signalling, MyD88 recruits IRAK4, thereby allowing the association of IRAK1. The TLR4 receptor complex-associated IRAK1 is phosphorylated by IRAK4, which in turn promotes the autophosphorylation and dissociation of IRAK1 from the receptor complex. Subsequently, IRAK1 interacts with TAK1-TAB1-TAB2 kinase complex-associated TRAF6. This interaction leads to the ubiquitylation of TRAF6, which induces the activation of TAK1 (23) . The activated TAK1 induces the phosphorylation of MAPKs and IKK, leading to the activation of transcription factors NF-kB and AP-1 (24, 25) . Upon activation of the MyD88-independent pathway, the TRAF3/TBK1 complex is activated, resulting in the phosphorylation and nuclear localization of IRF3 (26) . Our results showed that HS inhibited LPS-induced degradation of IRAK1 and IRAK4, concentration-dependently lowered protein levels of TRAF6, TRAF3, and phosphorylated forms of TAK1 and TBK1 ( Figure 4A ). These data further suggest the involvement of both MyD88-dependent and MyD88-independent pathways in the effects of HS.
A c t i v a t i o n o f I K K k i n a s e i n i t i a t e s t h e phosphorylation and degradation of IκBα resulting in the release of p50-p65 for nuclear translocation, and the eventual mediation of NF-κB-dependent transcriptional activity (27) . Studies have demonstrated that the PI3K/Akt pathway can regulate NF-κB signalling positively or negatively (28, 29) . Our results showed that HS concentration-dependently inhibited the phosphorylation of MAPKs (JNK, ERK and p38), IκBα and NF-κB p65. HS also inhibited the protein expression of iNOS and COX-2, the secretion of cytokines (IL-1β, IL-6 and TNF-α) and the production of NO in a concentration-dependent manner (Supplementary Figure 1S , http://www.biosciencetrends.com/action/ getSupplementalData.php?ID=26). These results are consistent with observations in previous reports (9, 20) and thus confirm the involevement of MAPKs and NF-κB signalling in the effects of HS. Our results also showed that HS concentration-dependently inhibited LPS-induced phosphorylation of PI3K, Akt, IKK, c-Jun, c-Fos and IRF3 ( Figure 4B ). These findings support the involvement of the MyD88-dependent pathways of MAPKs/AP-1 and PI3K/Akt, and the MyD88-independent pathway TBK1/IRF3 in the effects of HS. As stated previously, the role of Akt signalling in NF-κB activation is still controversial. Further studies are needed to delineate the inhibitory effect of HS on the Akt/NF-κB pathway.
Although we examined the proteins levels of TLR4, MyD88 and TRAM (data not shown) following HS treatment, we did not observe any significant changes. Previous studies suggest that some agents can alter the interaction between TLR4 receptor complex and LPS by competitively binding to the extracellular domain of TLR4 (30) . Therefore, further studies are needed to determine the possible abrogation of LPS-TLR4 interaction by HS in RAW264.7 cells. 
Conclusion
In this study, our results indicate that inhibition of the IRAK4/MAPKs/AP-1, IRAK4/MAPKs/NF-κB, IRAK4/PI3K/NF-κB and TRAF3/TBK1/IRF3 pathways is associated with the inhibitory effects of HS on inflammatory mediators in LPS-stimulated RAW264.7 cells. Therefore, not only do our experiments support the use of HS as a medicinal herb in the treatment of various inflammatory conditions, they also provide a novel pharmacological and mechanistic insight into the fundamentals of its activity. However, additional studies are warranted to further explore the molecular mechanism of action and identify the bioactive components of HS.
